Mindfulness group visit for Breast Cancer
Stanford University, Palo Alto, CA
Targeting 4 different conditionsMindfulness +1 moreN/AWaitlist AvailableLed by Lisa Golman-Rosas, PhDResearch Sponsored by Stanford UniversityEligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Self-identified anxiety (persistent worry or nervousness), depression (feeling sad, little interest or pleasure in doing things or hopeless), or sleep disturbance
Be older than 18 years old
Must not have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Upthrough study completion, an average of 1 year
Awards & highlights
Study Summary
This trial is testing a mindfulness program to see if it can help Latina breast cancer patients with anxiety and depression.
Eligible Conditions
- Breast Cancer
- Depression and Anxiety
- Mindfulness
- Sleep Disorder
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowSelect...
You have been feeling anxious, sad, or having trouble sleeping for a while.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acceptability change across session
Difference in Feasibility
Secondary outcome measures
Differences in Center for Epidemiological Studies-Depression (CES-D) between time points.
Differences in Generalized Anxiety Disorder-7 (GAD7) between time points.
Differences in PROMIS-SD between time points
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: Mindfulness group visitActive Control1 Intervention
Participants will attend 6 weekly educational and mindfulness sessions
Group II: Wait list controlPlacebo Group1 Intervention
Participants will be placed on a wait list
Find a site
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,293 Previous Clinical Trials
17,285,529 Total Patients Enrolled
57 Trials studying Breast Cancer
111,211 Patients Enrolled for Breast Cancer
Maria G Juarez-Reyes, MD, PhDStudy Director
Stanford UniversityLisa Golman-Rosas, PhDPrincipal Investigator
Stanford UniversityMedia Library
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any opportunities for patients to still participate in this clinical investigation?
"As per information on clinicaltrials.gov, the current recruitment period for this trial has ended as of June 21st 2022. Despite it no longer being open to enrollment, 2819 other trials are presently recruiting participants."
Answered by AI
Recent research and studies